Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Dec 28;34(2):82-84.
doi: 10.4103/1319-4534.305034. eCollection 2020 Apr-Jun.

Iris extramedullary hematopoiesis in choroidal melanoma

Affiliations

Iris extramedullary hematopoiesis in choroidal melanoma

Beatrice Gallo et al. Saudi J Ophthalmol. .

Abstract

Purpose: Extramedullary hematopoiesis (EMH) usually occurs in patients with loss of bone marrow hematopoietic function, and in a vast majority of cases, it involves the liver, the spleen, or the lymph nodes. We report EMH in the iris of patients enucleated for choroidal melanoma (CM).

Methods: We report a series of three patients with CM, two treated with primary enucleation and one with secondary enucleation.

Results: Histopathology revealed EMH in the iris of all patients.

Conclusion: EMH of the iris can be associated with CM in the absence of any hematological or systemic disorders. To the best of our knowledge, our work is the first report of this abnormal histopathological finding.

Keywords: Choroidal melanoma; enucleation; iris extramedullary hematopoiesis.

PubMed Disclaimer

Conflict of interest statement

There are no conflicts of interest.

Figures

Figure 1
Figure 1
(a) Iris of Patient 1 showing a central cluster of abnormal cells (H and E, ×20). Majority of the cells have dense eosinophilic cytoplasm and rounded nuclei consistent with erythroblasts. (b) Iris of Patient 2 showing clusters of mixed cells including erythroblasts (H and E, ×20) (positive with glycophorin A immunohistochemistry, c) and other primitive cells with little cytoplasm (positive with CD117 immunohistochemistry, not shown). (d) Iris stroma of Patient 3 showing clusters of erythroblasts (H and E, ×20)

References

    1. Singh AD, Turell ME, Topham AK. Uveal melanoma: Trends in incidence, treatment, and survival. Ophthalmology. 2011;118:1881–5. - PubMed
    1. Virgili G, Gatta G, Ciccolallo L, Capocaccia R, Biggeri A, Crocetti E, et al. Incidence of uveal melanoma in Europe. Ophthalmology. 2007;114:2309–15. - PubMed
    1. McLaughlin CC, Wu XC, Jemal A, Martin HJ, Roche LM, Chen VW. Incidence of noncutaneous melanomas in the U.S. Cancer. 2005;103:1000–7. - PubMed
    1. Kaliki S, Shields CL. Uveal melanoma: Relatively rare but deadly cancer. Eye (Lond) 2017;31:241–57. - PMC - PubMed
    1. Rodríguez A, Dueñas-Gonzalez A, Delgado-Pelayo S. Clinical presentation and management of uveal melanoma. Mol Clin Oncol. 2016;5:675–7. - PMC - PubMed